Diploma PLC (LON:DPLM - Get Free Report) insider Ian El-Mokadem purchased 500 shares of the company's stock in a transaction dated Monday, March 24th. The shares were bought at an average price of GBX 3,948 ($51.10) per share, for a total transaction of £19,740 ($25,550.09).
Diploma Stock Performance
Shares of LON:DPLM traded down GBX 98 ($1.27) during trading hours on Friday, hitting GBX 3,906 ($50.56). The stock had a trading volume of 1,091,654 shares, compared to its average volume of 527,572. The stock's fifty day simple moving average is GBX 4,363.28 and its 200 day simple moving average is GBX 4,370.37. The firm has a market capitalization of £5.21 billion, a price-to-earnings ratio of 44.90, a PEG ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. Diploma PLC has a 1-year low of GBX 3,468 ($44.89) and a 1-year high of GBX 4,808 ($62.23).
Diploma Increases Dividend
The firm also recently announced a dividend, which was paid on Friday, January 31st. Investors of record on Thursday, January 16th were given a GBX 42 ($0.54) dividend. This is a boost from Diploma's previous dividend of $17.30. This represents a yield of 0.93%. The ex-dividend date was Thursday, January 16th. Diploma's dividend payout ratio (DPR) is currently 65.52%.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. upped their price objective on Diploma from GBX 4,370 ($56.56) to GBX 4,420 ($57.21) and gave the stock a "neutral" rating in a research note on Tuesday, January 14th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of GBX 4,567.50 ($59.12).
View Our Latest Analysis on DPLM
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
